Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Medical representatives not equipped to meet doctors changing needs: Global Study

      Medical representatives not equipped to meet doctors changing needs: Global Study

      Ruby Khatun Khatun5 July 2017 12:54 PM IST
      The study reveals compelling evidence that suggests that healthcare reps are not fully equipped to meet the changing needs of health care...
      Alembic Pharma gets tentative USFDA nod for erectile dysfunction drug

      Alembic Pharma gets tentative USFDA nod for erectile dysfunction drug

      Ruby Khatun Khatun5 July 2017 12:46 PM IST
      New Delhi: Alembic Pharmaceuticals has received tentative approval from the US health regulator for vardenafil hydrochloride tablets used for...
      Glenmark Pharma gets UK drug regulator nod for OTC sale of anti-malarial drug

      Glenmark Pharma gets UK drug regulator nod for OTC sale of anti-malarial drug

      Ruby Khatun Khatun5 July 2017 12:46 PM IST
      New Delhi: Glenmark Pharma on Tuesday said the UK drug regulator MHRA has granted final approval to Glenmark Pharmaceuticals Europe for anti-malarial...
      Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

      Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

      Ruby Khatun Khatun5 July 2017 12:40 PM IST
      Mumbai: Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by...
      Zydus Cadila anti-diabetic drug gets USFDA marketing nod

      Zydus Cadila anti-diabetic drug gets USFDA marketing nod

      Ruby Khatun Khatun5 July 2017 12:39 PM IST
      New Delhi: Drug firm Zydus Cadila on Tuesday said it has received tentative approval from the US health regulator to market anti diabetic sitagliptin...
      CDSCO approves marketing of Russian biosimilar of rituximab in India

      CDSCO approves marketing of Russian biosimilar of rituximab in India

      Ruby Khatun Khatun5 July 2017 12:38 PM IST
      SAINT PETERSBURG: On 20th of June 2017, the Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab...
      FDA clears expanded use of cooling cap to reduce Alopecia during chemotherapy

      FDA clears expanded use of cooling cap to reduce Alopecia during chemotherapy

      Ruby Khatun Khatun5 July 2017 9:47 AM IST
      The U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during...
      Check out NPPA new mobile app to verify costs of medicines

      Check out NPPA new mobile app to verify costs of medicines

      Ruby Khatun Khatun4 July 2017 3:00 PM IST
      Public will now be able to track the information regarding their medicines they have been prescribed, their availability and prices through a new...
      Expect lower Q1 sales in India due to GST implementation: DRL

      Expect lower Q1 sales in India due to GST implementation: DRL

      Ruby Khatun Khatun4 July 2017 1:10 PM IST
      New Delhi: Drug major Dr Reddy's Laboratories (DRL) expects the first quarter of the ongoing fiscal to witness a temporary decline in sales in India...
      Indian pharma sector growth to moderate in next 3 yrs: ICRA

      Indian pharma sector growth to moderate in next 3 yrs: ICRA

      Ruby Khatun Khatun4 July 2017 1:09 PM IST
      New Delhi: Indian pharmaceutical industry is likely to witness moderation in growth in the next three years mainly due to decline in revenues from the...
      Strides Shasun gets USFDA go-ahead for anti-allergy drug

      Strides Shasun gets USFDA go-ahead for anti-allergy drug

      Ruby Khatun Khatun4 July 2017 11:33 AM IST
      New Delhi: Strides Shasun said it has received approval from the US health regulator for promethazine hydrochloride tablets used to treat allergy...
      Wockhardt gets USFDA nod for generic eye drops

      Wockhardt gets USFDA nod for generic eye drops

      Ruby Khatun Khatun4 July 2017 11:13 AM IST
      New Delhi: Drug firm Wockhardt has received approval from the US health regulator for generic Olopatadine HCl eye drops used for the treatment of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok